• 105 Citations
  • 6 h-Index
20032018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where sireen shilbayeh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Cytochrome P-450 CYP3A Medicine & Life Sciences
Tacrolimus Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Jordan Medicine & Life Sciences
Drug Monitoring Medicine & Life Sciences
Kidney Medicine & Life Sciences
Hyperlipidemias Medicine & Life Sciences
Genotype Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2018

  • 105 Citations
  • 6 h-Index
  • 16 Article
3 Citations (Scopus)

Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic

Shilbayeh, S. A. R., Almutairi, W. A., Alyahya, S. A., Alshammari, N. H., Shaheen, E. & Adam, A., 1 Feb 2018, In : International Journal of Clinical Pharmacy. 40, 1, p. 56-66 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Warfarin
Anticoagulants
International Normalized Ratio
Medication Adherence
Patient Compliance

Determination of cefdinir in human plasma using HPLC coupled with tandem mass spectroscopy: Application to bioequivalence studies

Tutunji, L. F., Al Bayyari, M., Shilbayeh, S. & Tutunji, M. F., 1 Jan 2015, In : Jordan Journal of Pharmaceutical Sciences. 8, 2, p. 123-139 17 p.

Research output: Contribution to journalArticleResearchpeer-review

cefdinir
Therapeutic Equivalency
Mass Spectrometry
High Pressure Liquid Chromatography
Cephalexin
2 Citations (Scopus)

Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment

Shilbayeh, S. A. R., Sy, S. K. B., Melhem, M., Zmeili, R. & Derendorf, H., 1 Jan 2015, In : Clinical Pharmacology in Drug Development. 4, 5, p. 387-394 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP3A
Pharmacokinetics
Genotype
Clinical Pharmacology
Drug Monitoring
8 Citations (Scopus)

A markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation

Sy, S. K. B., Heuberger, J., Shilbayeh, S., Conrado, D. J. & Derendorf, H., 30 Aug 2013, In : AAPS Journal. 15, 4, p. 1189-1199 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP3A
Markov Chains
Tacrolimus
Kidney Transplantation
Pediatrics